Resection and Immunotherapy for Recurrent Grade III Glioma

<table>Column analysis presenting median medical history for AA and AOD before and after immunotherapy. The medical history of patients with AA was in median 78.9 months shorter than that of patients with AOD while the OS after immunotherapy evolves similar. AA: anaplastic astrocytoma, AOD: anaplastic oligodendroglioma.</table>

International Scholarly Research Notices

fig1

Figure 1

Figure 1: Resection and Immunotherapy for Recurrent Grade III Glioma 